GlobalData on MSN22h
Medtronic reports late-breaking data from TAVR system trial for aortic stenosisMedtronic has reported late-breaking data from the Evolut Low Risk Trial’s five-year outcomes of the Evolut TAVR system.
Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback